Please assess the completion status of the following clinical trial:

Trial Title: Preventing Propofol-associated Injection Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria:~* weight \>40kg, \<100kg~* ambulatory surgery~Exclusion criteria:~* allergy to propofol or lidocaine~* taking opioids, benzodiazepines, or nonsteroidal antiinflammatory drugs (NSAIDs)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Saline pretreatment, saline admixture
- Lidocaine pretreatment (Type: ACTIVE_COMPARATOR): Lidocaine pretreatment / saline-propofol admixture
- Lidocaine-Propofol admixture (Type: ACTIVE_COMPARATOR): saline pretreatment / Lidocaine-propofol admixture

Based on this trial design, predict the completion outcome and termination type (if applicable).